Tag

BioInvent

Martin Welschof

BioInvent shows further positive clinical data

November 7, 2021

BioInvent International has announced additional …

Martin Welschof

BioInvent enters clinical trial collaboration

August 11, 2021

BioInvent International has entered into …

Martin Welschof

BioInvent receives IND approval

April 8, 2021

The U.S. Food and Drug …

Martin Welschof

BioInvent carries out a directed share issue of USD 116 million

February 23, 2021

The company plans to in …

Martin Welschof

BioInvent streamlines agreement on its BI-1206 antibody

January 12, 2021

BioInvent International has restructured a …

Martin Welschof

BioInvent and Cantargia sign manufacturing agreement

December 11, 2020

Cantargia and BioInvent International have …

Martin Welschof

BioInvent enters licensing agreement for Greater China region

October 28, 2020

BioInvent International and CASI Pharmaceuticals, …

Martin Welschof

BioInvent completes directed share issue of 487 million SEK

June 11, 2020

The Board of Directors of …

Björn Frendeus

BioInvent presents promising results and expands anti-TNFR2 program

May 15, 2020

BioInvent International has announced the …

Bioinvent

New clinical data from BioInvent

June 18, 2019

The company has announced the …

Mikael Oredsson

BioInvent and Transgene collaborate

December 7, 2017

BioInvent International and Transgene have …

Mikael Oredsson

The CEO of BioInvent resigns

October 25, 2017

BioInvent International announces that Michael …

BioInvent plans to expand therapeutic potential

October 24, 2017

BioInvent announces its plans to …

agreement

BioInvent and ThromboGenics amend agreement

August 4, 2017

BioInvent International and ThromboGenics NV …

thrombogenics

ThromboGenics initiates Phase II study

January 12, 2017

BioInvent’s collaboration partner ThromboGenics initiates …

mikael oredsson bioinvent

BioInvent announce collaboration and license agreement with Pfizer

December 21, 2016

BioInvent International has entered into …

1
2